Luspatercept
( DrugBank: Luspatercept / KEGG DRUG: Luspatercept )
3 diseases
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
60 | Aplastic anemia | 4 |
61 | Autoimmune hemolytic anemia | 1 |
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
282 | Congenital dyserythropoietic anemia | 1 |
60. Aplastic anemia
Clinical trials : 305 / Drugs : 328 - (DrugBank : 91) / Drug target genes : 60 - Drug target pathways : 183
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
61. Autoimmune hemolytic anemia
Clinical trials : 183 / Drugs : 119 - (DrugBank : 42) / Drug target genes : 31 - Drug target pathways : 156
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
282. Congenital dyserythropoietic anemia
Clinical trials : 2 / Drugs : 3 - (DrugBank : 2) / Drug target genes : 3 - Drug target pathways : 7
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|